Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $128,192 - $165,952
-3,200 Reduced 14.75%
18,500 $741,000
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $444,690 - $581,940
12,200 Added 128.42%
21,700 $1.03 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $96,669 - $123,165
2,300 Added 31.94%
9,500 $411,000
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $151,865 - $180,705
-3,500 Reduced 32.71%
7,200 $364,000
Q3 2023

Nov 15, 2023

BUY
$38.5 - $47.13 $411,950 - $504,291
10,700 New
10,700 $485,000
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $371,200 - $465,200
10,000 New
10,000 $378,000
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $361,494 - $490,200
-11,400 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $29,880 - $37,040
1,000 Added 9.62%
11,400 $407,000
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $417,443 - $572,130
-16,300 Reduced 61.05%
10,400 $318,000
Q2 2021

Aug 06, 2021

BUY
$34.54 - $47.25 $107,074 - $146,475
3,100 Added 13.14%
26,700 $1.06 Million
Q1 2021

May 14, 2021

SELL
$42.51 - $63.78 $1.18 Million - $1.77 Million
-27,700 Reduced 54.0%
23,600 $1.06 Million
Q4 2020

Feb 12, 2021

BUY
$45.3 - $60.27 $1.78 Million - $2.37 Million
39,300 Added 327.5%
51,300 $2.93 Million
Q3 2020

Nov 13, 2020

SELL
$47.45 - $62.95 $218,270 - $289,570
-4,600 Reduced 27.71%
12,000 $582,000
Q2 2020

Aug 13, 2020

SELL
$46.85 - $61.05 $313,895 - $409,035
-6,700 Reduced 28.76%
16,600 $986,000
Q1 2020

May 11, 2020

SELL
$41.6 - $63.4 $1.82 Million - $2.77 Million
-43,700 Reduced 65.22%
23,300 $1.12 Million
Q4 2019

Feb 12, 2020

BUY
$53.85 - $65.27 $118,470 - $143,594
2,200 Added 3.4%
67,000 $4.04 Million
Q3 2019

Nov 14, 2019

BUY
$59.06 - $72.15 $159,462 - $194,805
2,700 Added 4.35%
64,800 $3.83 Million
Q2 2019

Aug 20, 2019

SELL
$62.09 - $86.14 $701,617 - $973,382
-11,300 Reduced 15.4%
62,100 $3.99 Million
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $2.45 Million - $3.76 Million
46,300 Added 170.85%
73,400 $5.96 Million
Q4 2018

Feb 14, 2019

SELL
$43.37 - $59.54 $1.84 Million - $2.53 Million
-42,500 Reduced 61.06%
27,100 $1.39 Million
Q3 2018

Nov 14, 2018

SELL
$42.88 - $53.7 $145,792 - $182,580
-3,400 Reduced 4.66%
69,600 $3.59 Million
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $405,536 - $506,460
9,200 Added 14.42%
73,000 $3.22 Million
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $5,030 - $6,439
-100 Reduced 0.16%
63,800 $3.21 Million
Q3 2017

Nov 15, 2017

BUY
$45.56 - $59.57 $2.91 Million - $3.81 Million
63,900
63,900 $3.24 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.12B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.